Eeva K. Salminen
Department of Oncology and Radiotherapy
Turku University Hospital
Turku
Finland
Name/email consistency: high
- Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer. Salminen, E.K., Pukkala, E., Kiel, K.D., Hakulinen, T.T. Int. J. Radiat. Oncol. Biol. Phys. (2006)
- Palliative chemotherapy with trofosfamide in advanced prostate cancer. Salminen, E.K., Sundström, J., Nikkanen, V. Anticancer Res. (2006)
- Survival markers related to bone metastases in prostate cancer. Salminen, E.K., Kallioinen, M.J., Ala-Houhala, M.A., Vihinen, P.P., Tiitinen, S.L., Varpula, M., Vahlberg, T.J. Anticancer Res. (2006)
- Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Salminen, E.K., Portin, R.I., Koskinen, A.I., Helenius, H.Y., Nurmi, M.J. Cancer (2005)
- Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer. Salminen, E., Palmu, S., Vahlberg, T., Roberts, P.J., Söderström, K.O. World J. Gastroenterol. (2005)
- Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer. Salminen, E., Ala-Houhala, M., Korpela, J., Varpula, M., Tiitinen, S.L., Halleen, J.M., Väänänen, H.K. Acta. Oncol (2005)
- Dietary attitudes and changes as well as use of supplements and complementary therapies by Australian and Finnish women following the diagnosis of breast cancer. Salminen, E., Bishop, M., Poussa, T., Drummond, R., Salminen, S. Eur. J. Clin. Nutr (2004)
- Unmet needs in information flow between breast cancer patients, their spouses, and physicians. Salminen, E., Vire, J., Poussa, T., Knifsund, S. Support. Care. Cancer (2004)
- Trends in the use of androgen deprivation in prostate cancer. Salminen, E.K., Wickström, J.E., Vahlberg, T., Duchesne, G.M. Acta. Oncol (2004)
- Associations between serum testosterone fall and cognitive function in prostate cancer patients. Salminen, E.K., Portin, R.I., Koskinen, A., Helenius, H., Nurmi, M. Clin. Cancer Res. (2004)
- Docetaxel with epirubicin--investigations on cardiac safety. Salminen, E., Syvänen, K., Korpela, J., Varpula, M., Antila, K., Varjo, P., Ekholm, E. Anticancer. Drugs (2003)
- Androgen deprivation and cognition in prostate cancer. Salminen, E., Portin, R., Korpela, J., Backman, H., Parvinen, L.M., Helenius, H., Nurmi, M. Br. J. Cancer (2003)
- Female patients tend to alter their diet following the diagnosis of rheumatoid arthritis and breast cancer. Salminen, E., Heikkilä, S., Poussa, T., Lagström, H., Saario, R., Salminen, S. Prev. Med (2002)
- FDG-PET imaging in the management of non-small-cell lung cancer. Salminen, E., Mac Manus, M. Ann. Oncol. (2002)
- Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice. Salminen, E., Hogg, A., Binns, D., Frydenberg, M., Hicks, R. Acta. Oncol (2002)
- Breast cancer patients have unmet needs for dietary advice. Salminen, E., Bishop, M., Poussa, T., Drummond, R., Salminen, S. Breast (2002)
- Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer. Salminen, E., Mac Manus, M. Ann. Med. (2001)
- Testicular seminoma and diabetes in twins. Salminen, E., Sundström, J., Sainio-Pöllänen, S., Pöllänen, P., Kaprio, J. Acta. Oncol (2000)









